Chest

1. PROVENCHER S, Mai V, Bonnet S
   Managing Pulmonary Arterial Hypertension With Cardiopulmonary Comorbidities.
   Chest. 2024;165:682-691.
   

   >> Share

   
   
2. LONGINO A, Martin K, Leyba K, Siegel G, et al
   Prospective Evaluation of Venous Excess Ultrasound for Estimation of Venous Congestion.
   Chest. 2024;165:590-600.
   

   >> Share

   
   

   
   Circ Res

3. ECKLE T, Bertazzo J, Khatua TN, Fatemi Tabatabaei SR, et al
   Circadian Influences on Myocardial Ischemia-Reperfusion Injury and Heart Failure.
   Circ Res. 2024;134:675-694.
   

   >> Share

   
   

   
   Circulation

4. CLELAND JGF
   Nature and Magnitude of the Benefits of Dapagliflozin and Empagliflozin for Heart Failure.
   Circulation. 2024;149:839-842.
   

   >> Share

   
   
5. VELIKANOVA D, Poyhonen P, Lehtonen J, Simonen P, et al
   End-Stage Heart Failure in Cardiac Sarcoidosis.
   Circulation. 2024;149:885-887.
   

   >> Share

   
   
6. BAWASKAR P, Thomas N, Ismail KF, Guo Y, et al
   Non-ischemic or Dual Cardiomyopathy in Patients with Coronary Artery Disease.
   Circulation. 2023 Nov 6. doi: 10.1161/CIRCULATIONAHA.123.067032.
   

   >> Share

   
   

   
   Eur Heart J

7. AHN HJ, An HY, Ryu G, Lim J, et al
   Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study.
   Eur Heart J. 2024 Jan 17:ehad869. doi: 10.1093.
   

   >> Share

   
   
8. ORAII A, Healey JS, Kowalik K, Pandey AK, et al
   Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis of clinical trials.
   Eur Heart J. 2024 Jan 9:ehad811. doi: 10.1093.
   

   >> Share

   
   
9. SCHUERMANS A, Vlasschaert C, Nauffal V, Cho SMJ, et al
   Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias.
   Eur Heart J. 2024;45:791-805.
   

   >> Share

   
   

   
   Eur J Heart Fail

10. KRESOJA KP, Rosch S, Schober AR, Fengler K, et al
    Implications of tricuspid regurgitation and right ventricular volume overload in patients with heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2024 Mar 11. doi: 10.1002/ejhf.3195.
    

    >> Share

    
    
11. COX ZL, Testani JM
    The salt paradox in heart failure.
    Eur J Heart Fail. 2024 Mar 11. doi: 10.1002/ejhf.3194.
    

    >> Share

    
    
12. WOOD N, Straw S, Cheng CW, Hirata Y, et al
    Sodium-glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction.
    Eur J Heart Fail. 2024 Mar 11. doi: 10.1002/ejhf.3192.
    

    >> Share

    
    
13. PEIKERT A, Vaduganathan M, Claggett BL, Kulac IJ, et al
    Dapagliflozin in patients with heart failure and previous myocardial infarction: A participant-level pooled analysis of DAPA-HF and DELIVER.
    Eur J Heart Fail. 2024 Mar 15. doi: 10.1002/ejhf.3184.
    

    >> Share

    
    

    
    Int J Cardiol

14. BACKHAUS SJ, Schulz A, Lange T, Schmidt-Schweda LS, et al
    Prognostic and diagnostic implications of impaired rest and exercise-stress left atrial compliance in heart failure with preserved ejection fraction: Insights from the HFpEF stress trial.
    Int J Cardiol. 2024 Mar 11:131949. doi: 10.1016/j.ijcard.2024.131949.
    

    >> Share

    
    
15. SPERLONGANO S, Benfari G, Ilardi F, Lisi M, et al
    Role of speckle tracking echocardiography beyond current guidelines in cardiac resynchronization therapy.
    Int J Cardiol. 2024;402:131885.
    

    >> Share

    
    

    
    J Am Coll Cardiol

16. MADDOX TM, Januzzi JL Jr, Allen LA, Breathett K, et al
    2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2024 Mar 2:S0735-1097(23)08354.
    

    >> Share

    
    
17. GONZALEZ-LOPEZ E, McPhail ED, Salas-Anton C, Dominguez F, et al
    Histological Typing in Patients With Cardiac Amyloidosis: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:1085-1099.
    

    >> Share

    
    

    
    J Card Fail

18. SKOWRONSKI J, Hajduczok AG, DiChiacchio L
    Synergy, not Silos: The Intersection of Medical and Surgical Training in Advanced Heart Failure.
    J Card Fail. 2024 Mar 7:S1071-9164(24)00074.
    

    >> Share

    
    
19. GANGAVELLI A, Liu Z, Wang J, Okoh A, et al
    Poor Medication Access as a Driver of Excess Heart Failure Readmissions Among Patients Living in Economically Deprived Neighborhoods.
    J Card Fail. 2024 Mar 6:S1071-9164(24)00076.
    

    >> Share

    
    
20. GREWAL JS, Sengupta PP
    Pitfalls and Opportunities for the Growing Role of AI in Heart Failure.
    J Card Fail. 2024 Mar 11:S1071-9164(24)00078.
    

    >> Share

    
    
21. GOYAL P, Didomenico RJ, Pressler SJ, Ibeh C, et al
    Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement.
    J Card Fail. 2024;30:488-504.
    

    >> Share

    
    

    
    J Thorac Cardiovasc Surg

22. BLEIWEIS MS, Philip J, Peek GJ, Jacobs JP, et al
    Commentary: Challenges associated with long-term implantable ventricular assist device support in children.
    J Thorac Cardiovasc Surg. 2024;167:1429-1430.
    

    >> Share

    
    
23. CHO J, Tunuguntla HP, Tume SC, Spinner JA, et al
    Long-term Implantable Ventricular Assist Device Support in Children.
    J Thorac Cardiovasc Surg. 2023 Oct 30:S0022-5223(23)01005.
    

    >> Share

    
    
24. WERT L, Stewart GC, Mehra MR, Milwidsky A, et al
    A multicenter evaluation of external outflow graft obstruction with a fully magnetically levitated left ventricular assist device.
    J Thorac Cardiovasc Surg. 2024;167:1322-1330.
    

    >> Share

    
    

    
    PLoS One

25. CAGGIANELLI G, Alivernini F, Chirico A, Iovino P, et al
    The relationship between caregiver contribution to self-care and patient quality of life in heart failure: A longitudinal mediation analysis.
    PLoS One. 2024;19:e0300101.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share